BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2022 11:15:04 AM | Browse: 257 | Download: 535
 |
Received |
|
2022-03-17 08:41 |
|
Peer-Review Started |
|
2022-03-17 08:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-19 01:52 |
|
Revised |
|
2022-04-26 12:19 |
|
Second Decision |
|
2022-06-22 09:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-06-26 23:44 |
|
Articles in Press |
|
2022-06-26 23:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-22 00:09 |
|
Publish the Manuscript Online |
|
2022-07-26 11:15 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Stem cell therapy for insulin-dependent diabetes: Are we still on the road?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lu Yang, Zhu-Meng Hu, Fang-Xu Jiang and Wei Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of China |
81471081 |
| Natural Science Foundation of Fujian Province, China |
2019J01010 |
| Xiamen Research Foundation for Science and Technology Project |
3502Z20194037 |
| Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University |
PM201809170005 |
|
| Corresponding Author |
Wei Wang, MD, Doctor, Department of Endocrinology, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, No. 2000 Xiang'an East Road, Xiang'an District, Xiamen 361100, Fujian Province, China. wwei19742007@hotmail.com |
| Key Words |
Diabetes mellitus; Stem cell therapy; Transplantation; β cell; Differentiation |
| Core Tip |
Diabetes mellitus is one of the major health problems. Although traditional treatments such as exogenous insulin injection can relieve diabetes to a certain extent, they have failed to achieve a radical cure. Stem cell replacement therapy is a promising treatment for diabetes. So in this review, we introduce the development schedule of mouse and human embryonic islets and summarize the important research progressions in stem cell therapy for diabetes. |
| Publish Date |
2022-07-26 11:15 |
| Citation |
Yang L, Hu ZM, Jiang FX, Wang W. Stem cell therapy for insulin-dependent diabetes: Are we still on the road? World J Stem Cells 2022; 14(7): 503-512 |
| URL |
https://www.wjgnet.com/1948-0210/full/v14/i7/503.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v14.i7.503 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
